NAICONS SRL
Desconocido
BlueRemediomics: BlueRemediomics Harnessing the marine microbiome for novel sustainable biogenics and ecosystem serv...
NAICONS SRL
participó en un
HORIZON EUROPE:
HORIZON-CL6-2022-CIRCBIO-01
Marine microbial communities perform critical life sustaining functions on Earth and represent a vast unexploited treasure trove of bioresou...
2022-10-07 - 2026-11-30 | Financiado
2022-10-07 - 2026-11-30 | Financiado
BREAKthrough: Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria throu...
NAICONS SRL
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2021-DN-01
Antimicrobial resistance, which is caused by multi-drug-resistant bacterial pathogens is a global health emergency. Gram-negative bacteria (...
2022-07-14 - 2026-12-31 | Financiado
2022-07-14 - 2026-12-31 | Financiado
MARBLES: Marine Biodiversity as Sustainable Resource of Disease Suppressive Microbes and Bioprotectants for A...
NAICONS SRL
participó en un
H2020:
H2020-FNR-2020
MARBLES will use a novel and systematic approach to access and exploit marine microbial biodiversity for sustainable bioprospecting to disco...
2021-04-21 - 2026-04-30 | Financiado
2021-04-21 - 2026-04-30 | Financiado
PEST-BIN: Pioneering Strategies Against Bacterial Infections
NAICONS SRL
participó en un
H2020:
H2020-MSCA-ITN-2020
The World Health Organisation named antibiotic resistance as one of the greatest threats to global health, predicting the advent of infectio...
2020-08-28 - 2024-12-31 | Financiado
2020-08-28 - 2024-12-31 | Financiado
INNOTARGETS: Innvative approaches to identification of metabolic Targets for antimicrobials
NAICONS SRL
participó en un
H2020:
H2020-MSCA-ITN-2020
Antimicrobial resistance (AMR) is a challenge to human health and health-systems, and we need novel antimicrobials or drugs that can re-sens...
2020-08-13 - 2025-11-30 | Financiado
2020-08-13 - 2025-11-30 | Financiado
CARTNET: Combatting Antimicrobial Resistance Training Network
NAICONS SRL
participó en un
H2020:
H2020-MSCA-ITN-2017
CARTNET trains young researchers in Europe to address serious and global problems of antibiotic resistance. Disease-causing bacteria are bec...
2017-08-31 - 2021-12-31 | Financiado
2017-08-31 - 2021-12-31 | Financiado
Rafts4Biotech: Synthetic bacterial lipid rafts to optimize industrial bioprocesses
NAICONS SRL
participó en un
H2020:
H2020-NMBP-2016-2017
Genetic tractability of bacterial cells allows generating synthetic microbial chassis platforms (SMCPs) with remarkable biotechnological app...
2016-11-14 - 2021-06-30 | Financiado
2016-11-14 - 2021-06-30 | Financiado
TOPCAPI: Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients
NAICONS SRL
participó en un
H2020:
H2020-NMBP-2016-2017
TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE227...
2016-11-09 - 2021-09-30 | Financiado
2016-11-09 - 2021-09-30 | Financiado
Train2Target: An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics Targeting function...
NAICONS SRL
participó en un
H2020:
H2020-MSCA-ITN-2016
Train2Target is a multidisciplinary European Training Network built to address the challenge of the discovery of alternative antimicrobials....
2016-08-31 - 2020-12-31 | Financiado
2016-08-31 - 2020-12-31 | Financiado
NOMORFILM: Novel marine biomolecules against biofilm. Application to medical devices.
NAICONS SRL
participó en un
H2020:
H2020-BG-2014-2015
Microalgae are a source of secondary metabolites useful as new bioactive compounds. Activity of these compounds against bacterial pathogens...
2015-02-19 - 2019-12-31 | Financiado
2015-02-19 - 2019-12-31 | Financiado
* No se disponen de datos de la empresa actual.